Steven Cohen Exelixis, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Exelixis, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 200,000 shares of EXEL stock, worth $7.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

200,000

Holding current value

$7.19 Million

% of portfolio

0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $50.5 Million - $60.3 Million	-2,653,176 Reduced 80.14%	657,404 $14.4 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $1.27 Million - $1.44 Million	-70,159 Reduced 2.08%	3,310,580 $63.3 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $49.6 Million - $59.1 Million	-3,043,061 Reduced 47.37%	3,380,739 $65.6 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $82.3 Million - $95.6 Million	5,500,100 Added 595.44%	6,423,800 $103 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $6.45 Million - $9.16 Million	411,100 Added 80.2%	923,700 $14.5 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $111 Million - $147 Million	-6,341,700 Reduced 92.52%	512,600 $10.7 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $44.8 Million - $59.7 Million	2,632,154 Added 62.34%	6,854,300 $155 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $33.1 Million - $45.7 Million	2,089,846 Added 98.01%	4,222,146 $77.2 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $5.46 Million - $7.08 Million	334,800 Added 18.63%	2,132,300 $45.1 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $2 Million - $2.84 Million	111,246 Added 6.6%	1,797,500 $32.8 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $34.6 Million - $42.5 Million	-1,686,646 Reduced 50.01%	1,686,254 $38.1 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $42.2 Million - $56.9 Million	2,294,559 Added 212.79%	3,372,900 $67.7 Million
Q3 2020 Nov 16, 2020	BUY	$20.67 - $26.94 $14.2 Million - $18.5 Million	687,027 Added 175.57%	1,078,341 $26.4 Million
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $9.36 Million - $15.6 Million	-568,951 Reduced 59.25%	391,314 $9.29 Million
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $13.9 Million - $20.9 Million	960,265 New	960,265 $16.5 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $1.72 Million - $2.15 Million	-113,744 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$17.68 - $22.65 $2.01 Million - $2.58 Million	113,744 New	113,744 $2.01 Million
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $1.96 Million - $2.48 Million	-100,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $1.64 Million - $2.62 Million	-120,343 Reduced 54.62%	100,000 $1.97 Million
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $3.5 Million - $4.94 Million	220,343 New	220,343 $3.9 Million
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $4.64 Million - $5.61 Million	-250,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $3.76 Million - $5.42 Million	-169,900 Reduced 40.46%	250,000 $5.54 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $4.72 Million - $6.03 Million	194,900 Added 86.62%	419,900 $12.8 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $5.25 Million - $6.58 Million	225,000	225,000 $5.45 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account